Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Characterisation and intervention study in patients with long-term use of nasal decongestants
2019-003254-91Phase 4Active
- Sponsor
- Ghent University Hospital
- Start
- Jul 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of mometasone in rhinitis medicamentosa (RM), sponsored by Ghent University Hospital. Primary endpoint: Primary: success rate of nasal decongestant withdrawal. Started Jul 2020; status: active.
02
Drugs
mometasone
03
Conditions
rhinitis medicamentosa (RM)
Beyond the preview
Go deeper on 2019-003254-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003254-91.